CA3124806C - Chromatographic media for storage and delivery of therapeutic biologics and small molecules - Google Patents

Chromatographic media for storage and delivery of therapeutic biologics and small molecules Download PDF

Info

Publication number
CA3124806C
CA3124806C CA3124806A CA3124806A CA3124806C CA 3124806 C CA3124806 C CA 3124806C CA 3124806 A CA3124806 A CA 3124806A CA 3124806 A CA3124806 A CA 3124806A CA 3124806 C CA3124806 C CA 3124806C
Authority
CA
Canada
Prior art keywords
composite material
certain embodiments
dried
stabilizing agent
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3124806A
Other languages
English (en)
French (fr)
Other versions
CA3124806A1 (en
Inventor
John A. Chickosky
Charles H. Honeyman
Amro Ragheb
Molly S. Mcglaughlin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Millipore Ltd
Original Assignee
Merck Millipore Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Millipore Ltd filed Critical Merck Millipore Ltd
Publication of CA3124806A1 publication Critical patent/CA3124806A1/en
Application granted granted Critical
Publication of CA3124806C publication Critical patent/CA3124806C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA3124806A 2012-01-19 2013-01-18 Chromatographic media for storage and delivery of therapeutic biologics and small molecules Active CA3124806C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261588312P 2012-01-19 2012-01-19
US61/588,312 2012-01-19
CA2861932A CA2861932C (en) 2012-01-19 2013-01-18 Chromatographic media for storage and delivery of therapeutic biologics and small molecules

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2861932A Division CA2861932C (en) 2012-01-19 2013-01-18 Chromatographic media for storage and delivery of therapeutic biologics and small molecules

Publications (2)

Publication Number Publication Date
CA3124806A1 CA3124806A1 (en) 2013-07-27
CA3124806C true CA3124806C (en) 2023-09-26

Family

ID=48797397

Family Applications (2)

Application Number Title Priority Date Filing Date
CA3124806A Active CA3124806C (en) 2012-01-19 2013-01-18 Chromatographic media for storage and delivery of therapeutic biologics and small molecules
CA2861932A Active CA2861932C (en) 2012-01-19 2013-01-18 Chromatographic media for storage and delivery of therapeutic biologics and small molecules

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2861932A Active CA2861932C (en) 2012-01-19 2013-01-18 Chromatographic media for storage and delivery of therapeutic biologics and small molecules

Country Status (10)

Country Link
US (2) US20130189322A1 (enExample)
EP (1) EP2804634B1 (enExample)
JP (2) JP6552822B2 (enExample)
KR (1) KR102113296B1 (enExample)
AU (1) AU2013209620B2 (enExample)
CA (2) CA3124806C (enExample)
DK (1) DK2804634T3 (enExample)
ES (1) ES2750211T3 (enExample)
IN (1) IN2014DN06817A (enExample)
WO (1) WO2013109825A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY178616A (en) 2012-09-17 2020-10-19 Grace W R & Co Chromatography media and devices
US9738683B2 (en) 2013-07-25 2017-08-22 Bio-Rad Laboratories, Inc. Enhanced functionality and delivery of a protein from a porous substrate
FR3012978A1 (fr) * 2013-11-12 2015-05-15 Biocarecell Filtre biocompatible et procede de fabrication d'un filtre biocompatible.
JP6853670B2 (ja) 2014-01-16 2021-04-07 ダブリュー・アール・グレース・アンド・カンパニー−コーンW R Grace & Co−Conn 親和性クロマトグラフィー媒体及びクロマトグラフィーデバイス
JP6914189B2 (ja) 2014-05-02 2021-08-04 ダブリュー・アール・グレース・アンド・カンパニー−コーンW R Grace & Co−Conn 官能化担体材料並びに官能化担体材料を作製及び使用する方法
IS3008B (is) * 2014-05-14 2018-12-15 Calor ehf Stöðgandi lausnir fyrir prótín og peptíð
CN107921407B (zh) 2015-06-05 2022-07-05 格雷斯公司 生物处理吸附澄清剂及其制备和使用方法
CA3097058A1 (en) * 2018-04-16 2019-10-24 Merck Patent Gmbh Additives for protein formulations to improve thermal stability

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059654A (en) * 1983-02-14 1991-10-22 Cuno Inc. Affinity matrices of modified polysaccharide supports
JPH0779694B2 (ja) * 1985-07-09 1995-08-30 カドラント バイオリソ−シズ リミテツド 蛋白質および同類品の保護
CA2073511A1 (en) * 1990-11-14 1992-05-29 Matthew R. Callstrom Conjugates of poly(vinylsaccharide) with proteins for the stabilization of proteins
US5159049A (en) * 1991-04-22 1992-10-27 Allen Robert C Method for stabilizing polyacrylamide gels
US5583162A (en) * 1994-06-06 1996-12-10 Biopore Corporation Polymeric microbeads and method of preparation
US6284282B1 (en) * 1998-04-29 2001-09-04 Genentech, Inc. Method of spray freeze drying proteins for pharmaceutical administration
SE9904475D0 (sv) * 1999-12-08 1999-12-08 Artursson Nucleic acid delivery system
US6896894B2 (en) * 2001-10-30 2005-05-24 Battelle Memorial Institute Proteins stabilized with polysaccharide gums
NZ535008A (en) * 2002-02-08 2005-09-30 Alkermes Inc Polymer-based compositions for sustained release
US20040137004A1 (en) * 2002-03-19 2004-07-15 Glenn Gregory M Patch for transcutaneous immunization
US6666281B2 (en) 2002-03-19 2003-12-23 Deere & Company Bearing guard for a ground-working implement
EP2143482A1 (en) * 2003-02-19 2010-01-13 Natrix Separations Inc. Composite materials comprising supported porous gels
US7785769B2 (en) * 2003-07-25 2010-08-31 The United States of America as reprsented by the Secretary of the Navy Immobilization of oligonucleotides and proteins in sugar-containing hydrogels
EP1758671B9 (en) 2004-04-08 2014-02-19 Natrix Separations Inc. Membrane stacks
EP2168975A3 (en) * 2004-05-24 2012-01-11 Genvault Corporation Method of stably storing biomolecules in recoverable form
JP4806401B2 (ja) * 2004-06-07 2011-11-02 ナトリックス セパレイションズ インコーポレーテッド 支持型多孔質ゲルを含む安定な複合材料

Also Published As

Publication number Publication date
IN2014DN06817A (enExample) 2015-05-22
DK2804634T3 (da) 2019-11-04
JP2019011341A (ja) 2019-01-24
WO2013109825A1 (en) 2013-07-25
US20130189322A1 (en) 2013-07-25
AU2013209620B2 (en) 2017-06-15
JP2015504092A (ja) 2015-02-05
US20200069602A1 (en) 2020-03-05
EP2804634A1 (en) 2014-11-26
CA3124806A1 (en) 2013-07-27
KR20140117529A (ko) 2014-10-07
AU2013209620A1 (en) 2014-08-28
KR102113296B1 (ko) 2020-06-02
ES2750211T3 (es) 2020-03-25
EP2804634B1 (en) 2019-08-28
EP2804634A4 (en) 2015-07-22
JP6552822B2 (ja) 2019-07-31
CA2861932A1 (en) 2013-07-27
CA2861932C (en) 2021-09-14

Similar Documents

Publication Publication Date Title
US20200069602A1 (en) Chromatographic media for storage and delivery of therapeutic biologics and small molecules
ES2811137T3 (es) Membranas para cromatografía formadas por reacciones de polimerización clic de tiol-eno o tiol-ino
CA2514471C (en) Composite materials comprising supported porous gels
JP6082903B2 (ja) 創傷環境における治療因子の結合のためのアプタマー変性高分子材料
AU2010317563B2 (en) Hydrophobic interaction chromatography membranes, and methods of use thereof
JP7614197B2 (ja) 複合材料に配位子をカップリングするための方法
KR20200130387A (ko) 마크로보이드들을 갖는 이소포러스 메조포러스 비대칭 블록 코폴리머 재료들 및 이의 제조 방법
KR20150123309A (ko) 혼합-모드 크로마토그래피 막
US20140273158A1 (en) Chromatography Membranes Stable Under Caustic Conditions
Fernandes et al. Biobased monoliths for adenovirus purification
EP4365528A2 (en) Supercritical drying of chromatographic media
Zhang et al. Temperature responsive pore‐filled membranes based on a BSA/poly (N‐isopropylacrylamide) hydrogel

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20210909

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 12TH ANNIV.) - STANDARD

Year of fee payment: 12

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241207

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241207

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 13TH ANNIV.) - STANDARD

Year of fee payment: 13

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20251218

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20251218